Inflammation and Sepsis: Past, Present, and the Future

A critical burn injury is a unique trauma that often is accompanied by significant metabolic disturbances as well as perturbation of innate and adaptive immunity. Human skin is not only a barrier against environmental insults and against colonization of pathogenic microbes but, more importantly, it is an immune organ with significant surveillance and thermoregulatory functions. Therefore, it is hardly surprising that loss of large portions of skin as the result of burns results in impaired immunity, metabolic compromises, fluid shifts, and heat loss. Through improvements in resuscitation, critical care, nutritional support, and early closure of the burn wound during the past two decades, our ability to care for burn patients has resulted in a marked reduction in morbidity and mortality. However, nosocomial wound or pulmonary infections, especially in patients requiring ventilator assistance, remain a major problem.

[1]  Juan E. González,et al.  Messing with Bacterial Quorum Sensing , 2006, Microbiology and Molecular Biology Reviews.

[2]  A. V. Bubnoff Seeking New Antibiotics in Nature's Backyard , 2006, Cell.

[3]  G. Stormo,et al.  Molecular Diagnostics in Sepsis: From Bedside to Bench , 2006, Journal of the American College of Surgeons.

[4]  Nicki Panoskaltsis,et al.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. , 2006, The New England journal of medicine.

[5]  R. Gamelli,et al.  OxyR gene expression of Pseudomonas aeruginosa regulates bone marrow dendritic cell differentiation and function after burn sepsis , 2006 .

[6]  Roberto Rebeil,et al.  Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Gamelli,et al.  Immunologic Responses to Critical Injury and Sepsis , 2006, Journal of intensive care medicine.

[8]  R. Gamelli,et al.  New Perspectives for a New Century: Implications of Pathogen Responses for the Future of Antimicrobial Therapy , 2006, Journal of burn care & research : official publication of the American Burn Association.

[9]  Paul Martin,et al.  Inflammatory cells during wound repair: the good, the bad and the ugly. , 2005, Trends in cell biology.

[10]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[11]  I. Jutras,et al.  Phagocytosis: at the crossroads of innate and adaptive immunity. , 2005, Annual review of cell and developmental biology.

[12]  Kazuo Kobayashi,et al.  Macrophages in inflammation. , 2005, Current drug targets. Inflammation and allergy.

[13]  G. S. Chhatwal,et al.  Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice. , 2005, The Journal of infectious diseases.

[14]  Mehmet Toner,et al.  Application of genome-wide expression analysis to human health and disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Dixon,et al.  Functions of the Yersinia effector proteins in inhibiting host immune responses. , 2005, Current opinion in microbiology.

[16]  Dean Cheng,et al.  Pseudomonas aeruginosa Genome Database and PseudoCAP: facilitating community-based, continually updated, genome annotation , 2004, Nucleic Acids Res..

[17]  D. Herndon,et al.  Influence of systemic inflammatory response syndrome on host resistance against bacterial infections* , 2004, Critical care medicine.

[18]  Roger S Smith,et al.  Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. , 2003, The Journal of clinical investigation.

[19]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[20]  M. Schwacha Macrophages and post-burn immune dysfunction. , 2003, Burns : journal of the International Society for Burn Injuries.

[21]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[22]  J. W. Wilson,et al.  Mechanisms of bacterial pathogenicity , 2002, Postgraduate medical journal.

[23]  D. Chinkes,et al.  Reversal of catabolism by beta-blockade after severe burns. , 2001, The New England journal of medicine.

[24]  L. Moldawer,et al.  SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY , 2001, Shock.

[25]  D. Hassett,et al.  Role of the Pseudomonas aeruginosa oxyR-recG Operon in Oxidative Stress Defense and DNA Repair: OxyR-Dependent Regulation of katB-ankB, ahpB, andahpC-ahpF , 2000, Journal of bacteriology.

[26]  P. Delves,et al.  The Immune System , 2000 .

[27]  E. Abraham,et al.  Why immunomodulatory therapies have not worked in sepsis , 1999, Intensive Care Medicine.

[28]  S. Nasraway,et al.  Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock , 1998, The Lancet.

[29]  Wiklund Ra,et al.  First of two parts , 1997 .

[30]  B. G. Sparkes Immunological responses to thermal injury. , 1997, Burns : journal of the International Society for Burn Injuries.

[31]  R. Bone A personal experience with SIRS and MODS. , 1996, Critical care medicine.

[32]  R. Bone,et al.  Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.

[33]  R. Bone The sepsis syndrome. Definition and general approach to management. , 1996, Clinics in chest medicine.

[34]  T. Kupper,et al.  Immunity at the surface: homeostatic mechanisms of the skin immune system. , 1996, Life sciences.

[35]  L. DiPietro,et al.  WOUND HEALING: THE ROLE OF THE MACROPHAGE AND OTHER IMMUNE CELLS , 1995, Shock.

[36]  Bonnie L. Bassler,et al.  Bacterially Speaking , 2006, Cell.

[37]  R. Steinman,et al.  Dendritic cells: translating innate to adaptive immunity. , 2006, Current topics in microbiology and immunology.

[38]  J. Dunne,et al.  Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. , 2004, Surgical infections.

[39]  M. Eaman Immune system. , 2000, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[40]  S. Nasraway,et al.  Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. , 1998, Lancet.

[41]  P. Nyström,et al.  The systemic inflammatory response syndrome: definitions and aetiology. , 1998, The Journal of antimicrobial chemotherapy.

[42]  E. Faist The mechanisms of host defense dysfunction following shock and trauma. , 1996, Current topics in microbiology and immunology.